The landscape of dementia prognosis has developed dramatically with the advent of complex biomarkers, including amyloid PET scans, tau imaging, and blood-centered assessments that may detect Alzheimer's pathology a long time in advance of indications emerge. Whilst these technological developments depict amazing development in being familiar with n